Subscribe to Newsletter

Nicholas Vertommen

Nicolas Vertommen is Co-Founder and CEO of Hakobio at OUAT!, Belgium.

Content by Nicholas Vertommen:

 Manufacture Technology and Equipment

Looking to a New Reality

| Nicholas Vertommen

The path to market for a biosimilar involves an abbreviated approval process, focused on proving “biosimilarity”.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

October Issue of The Medicine Maker